Q32 Bio Inc. Deferred Tax Assets, Operating Loss Carryforwards
Q32 Bio Inc. (QTTB) had Deferred Tax Assets, Operating Loss Carryforwards of $58.66 million as of 2025-12-31, per its 10-K filed 2026-03-10.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Operating Loss Carryforwards, Components
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-03-10
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $58.66M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $32.55M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $88.55M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards $76.73M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards |
|---|---|
| 2025-12-31 | $58.66M 10-K · filed 2026-03-10 |
| 2024-12-31 | $32.55M 10-K · filed 2026-03-10 |
| 2023-12-31 | $88.55M 10-K · filed 2024-03-13 |
| 2022-12-31 | $76.73M 10-K · filed 2024-03-13 |
| 2021-12-31 | $100.42M 10-K · filed 2023-03-09 |
| 2020-12-31 | $72.84M 10-K · filed 2022-03-23 |
| 2019-12-31 | $41.59M 10-K · filed 2021-03-11 |
| 2018-12-31 | $14.85M 10-K · filed 2020-03-12 |
| 2017-12-31 | $9.18M 10-K · filed 2019-03-12 |